DEVELOPMENT OF FIRST-IN-CLASS ERAP2 INHIBITORS TO MODULATE THE CANCER IMMUNOPEPTIDOME

Collaborator poster on immunopeptidomics presented at the SITC 2023

Our collaborator, GreyWolf Therapeutics, has uncovered the effect of aminopeptidase ERAP2 inhibition for generating the de novo antitumor T-cell responses, thereby overcoming the resistance mechanism for current immune-oncology therapy.

Learn more about leveraging our TrueDiscovery® immunopeptidomics CRO services to overcome the challenges in immune-oncology.

Disclaimer: The contact information provided for poster download will also be shared with GreyWolf Therapeutics

Fill out the form to access this resource. Already a registered customer? Sign in to access this resource.

First Name

Last Name

Email

Phone

Company

Job Title

Country

Select state:

>Receive our newsletter for any of the following topics: Contract Research Services Products (Software, Kits, Reagents) Science & Technology By submitting this form, you confirm that you agree to the processing of your personal data by Biognosys as described in the Privacy Notice.

Back to Resources overview

Contact

Contact Form

Biognosys AG
Wagistrasse 21
8952 Schlieren
Switzerland

Phone: +41 44 738 20 40

US Offices
Biognosys Inc
70 Bridge St, Suite 104
Newton, MA 02458
United States

© 2024 Biognosys. All rights reserved.

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.